arrow
J

Judith Farrés

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
H指数:15
被引数:1,197

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Strengthening tuberculosis clinical trial implementation: operational challenges, lessons learned, and consensus recommendations from a Delphi study

加强结核病临床试验的实施:来自德尔菲研究的运营挑战、经验教训和共识建议

2026-10-010
OAAI
CD4+ T-Cell Markers Associated With Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic Acid and Ibuprofen as Adjunctive Therapy

CD4+ T细胞标记物与结核病治疗结局的关系:阿司匹林和对乙酰氨基酚作为辅助治疗IIB期试验的亚组分析

2026-07-290
OAAI
Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial

在广泛耐药和极广泛耐药结核病中使用辅助布洛芬的IIA期开放标签试点临床试验

2026-07-010
OAAI
Inflammatory and transcriptional profiles associated with structural and functional recovery in pre-XDR/XDR tuberculosis

与结构性和功能性恢复相关的广泛耐药/耐多药结核病的炎症和转录谱

2026-01-010
OAAI
Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence

欧盟和拉丁美洲国家胃腺癌的免疫分型研究,发现了免疫亚群和微生物组影响方面的全球性差异。

2025-03-200
OA
Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression
2025-01-050
OAAI
Design and functional characterization of a first-in-class irreversible inhibitor of HOIL-1-interacting protein (HOIP) with selective antitumor activity against B-cell non-Hodgkin lymphoma
2023-04-040
PRE
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
2022-06-137
OAAI